PAD Formulary : Surrey Heartlands
PAD - Prescribing Advisory Database
PLEASE NOTE : This is a development system.

For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.

You are here : Home > PAD Profile : Fluticasone with azelastine - Allergic rhinitis

PAD Profile : Fluticasone with azelastine - Allergic rhinitis

Keywords :
Hay fever, hayfever, antihistamines, nasal sprays, allergy, seasonal allergic rhinitis, intranasal antihistamines, pollen allergy, non-sedating antihistamines, fluticasone with azelastine nasal spray
Brand Names Include :
Dymista

Traffic Light Status

Status 1 of 1.

Status :
Green (see narrative)
Important
Formulations :
  • Nasal spray
Important Information :
Reserved for use where monotherapy is inadequate. Not 1st line.
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Links :
BNF NICE SPC
Comments :
No comments returned.
Documents :

Guidelines

The following guidelines are available for this indication.

Other Drugs

Other Indications

Additional Documents

Type
Document
Review Date
Guidelines (Local)
Hay fever - Guidelines - April 2023
01 January 2024

Committee Recommendations

Date
Committee Name
Narrative
05 April 2023
Surrey Heartlands Integrated Care System Area Prescribing Committee (APC)

The APC agreed Dymista (azelastine hydrochloride / fluticasone propionate) nasal spray as a treatment option for the treatment of perennial and seasonal allergic rhinitis in circumstances where:

  • fluticasone alone has demonstrated benefit
  • other corticosteroids are ineffective/not tolerated

In addition, patients requiring dose adjustments should remain on separate components.

Associated BNF Codes

12. Ear, Nose and Oropharynx
12.02.01. Drugs used in nasal allergy
This site uses its own and third party cookies to function properly and to improve performance, to maintain the session and to personalise user experience, as well as to obtain anonymous statistics about the use of the website. Visit our Privacy and Cookie Policy for more information on our data collection practices. By clicking 'Accept' you agree to our use of cookies for the purposes listed.
 Learn More